Major listed companies in the industry: Berry Genetics (000710); UW Genetics (300676); BioShares (600201), etc.
This article's core data: China's bio-economy market size;Bio-economy market competition;Bio-economy market size forecast
Industry Overview
According to the "14th Five-Year Plan", the industry is expected to grow in the next few years. Size Forecast
Industry Overview
According to the information in the "14th Five-Year Plan" for the development of bio-economy, the document specifies four key development areas of bio-economy. The first is biomedicine, the second is bio-agriculture, the third is biomass alternative applications, and the fourth is biosafety.
For the field of biomedicine, the "Plan" puts forward focusing on drugs, vaccines, advanced diagnostic and treatment technologies and equipment, biomedical materials, precision medicine, testing and biocontainment and other directions, to enhance the capacity for original innovation, to strengthen the scientific research on drug regulation, and to enhance the level of supply chain security for high-end products and equipment for biomedicine.
Industry development policy background
In recent years, China's rapid economic development, greatly promoting the development of bio-economic peripheral market. The construction of bio-economy platform relies on the development of cloud computing, big data, 5G and other new-generation information technology and software fields, and the country has also launched various types of supportive policies targeted at the development of such industries in recent years:
Industry Industry Chain Analysis
China's bio-economy industry chain upstream is mainly comprised of bio-industry-related The main upstream of China's bio-economic industry chain is dominated by the construction of theoretical systems and the supply of equipment, the midstream bio-economic industry includes four pillar industries: biomedicine, bio-agriculture, biomass substitution and biosafety industry, and the downstream application field also involves organic agriculture, green energy, and safety and security.
China's bio-economy industry chain includes leading companies in the fields of biomedicine, bio-agriculture, and biomass energy, etc. The upstream biotechnology research and development and equipment supply overlap with the midstream bio-economy industry layout to a large extent.
Global Industry Policy Overview
From the perspective of the strategic development of overseas bio-economy, the world's major economies have been around the bio-economy for a clear plan, in which the United States launched the latest "Bio-economy Plan: Framework for Implementation" in 2022, which puts forward the need to continue to develop ecological sustainability.
Industry Development History
Overall, the world's economic structure has gone through four main stages of development, before the 18th century, mainly in the agricultural economy, the first industrial revolution, the arrival of the industrial economy has made the brain labor gradually become the main mode of labor. 20-21st century, the information economy provides a strong impetus to the development of globalization. The information economy in the 20th and 21st centuries provided a strong impetus to the development of globalization, and after the first decade of the 21st century, major economies around the world began to vigorously develop the bio-economy industry, and China also included bio-economy in its national strategic development plan in the "14th Five-Year Plan".
Chinese industry development status
1, China's bio-industry overall scale and structure
China's bio-industry scale has continued to grow over the past 10 years, from 2.3 trillion yuan in 2012 to 6.1 trillion yuan in 2021, with a compound annual growth rate of more than 15%. growth rate of more than 15%, in terms of GDP share in 2021 the bio-industry GDP share reached 5.3%.
From the perspective of the scale of China's bio-resource valorization, the scale of China's bio-resource valorization more than doubled from 2012 to 2021, increasing from 640 million yuan in 2012 to more than 1.3 billion yuan in 2021, with the growth rate of bio-resource valorization scale in 2021 exceeding 10%.
2. Analysis of the status of China's bio-economy industry
From the perspective of the proportion of GDP occupied by the scale of China's bio-economy, the industry's supportive role in the sustainable development of the economy is being continuously strengthened, with the scale of China's bio-economy accounting for more than 14% of the GDP in 2012, and reaching 16.1% in 2021. As a brand new economic form following the agricultural economy, industrial economy and information economy, the bio-economy is of great significance in promoting the high-quality development of China's economy.
From the situation of industry penetration rate, China's primary industry bio-economy penetration rate decreases from more than 66% in 2012 to less than 50% in 2021; the secondary industry bio-economy penetration rate increases from about 33% in 2012 to more than 50% in 2021; the tertiary industry bio-economy penetration rate increases from 0.1% in 2012 to 1.4%. From the trend point of view in the future China's bio-economy in the secondary and tertiary industries is expected to further expand the proportion.
3, China's bio-economy industry market size volume measurement
According to the data published by CCID, China's bio-economy has achieved rapid development during 2012-2021, with the industry scale increasing from 7.6 trillion yuan in 2012 to 18.4 trillion yuan in 2021, with an annual average compound annual growth rate of more than 10%. Accompanied by the life sciences, biotechnology and other continued advancement, the bio-economy has become the most innovative and dynamic conduct and form.
Industry Competition Pattern Analysis
1, industry enterprise competition pattern
According to the data provided by the enterprise cat, China's bio-economy industry has more than 70,000 enterprises, the industry volume scale is increasing, from the date of establishment of enterprises, China's bio-economy in 2022 will be the most innovative and dynamic. From the point of view, in 2022 China's bio-economy industry enterprises within the newly established companies reached a new high in recent years, as of the beginning of December 2022 China's bio-economy industry 2022 annual establishment of more than 16,000 companies.
From the perspective of enterprise competitiveness, Foresight combines the bio-economy business revenue scale of major enterprises in China's bio-economy industry and the "2021 China's biopharmaceutical research and development strength rankings of TOP50", and summarizes the current competition pattern of enterprises in China's bio-economy industry by comparing the development status quo of the enterprise's technological scale, and comprehensively sees that Hengrui Pharmaceuticals and Baizi Divine State have Certain competitive advantages:
2, industry regional competition analysis
From the perspective of regional distribution, in 2021 China's bio-economy in general presents a gradient development trend, the regional development of the development of competing, blossoming situation. Among them, the scale of bio-economy industry in Shandong, Jiangsu, Guangdong, Sichuan and Henan has exceeded the trillion scale, which is the backbone of China's bio-economy industry development.
Industry Development Trend Analysis
The Prospective Industry Research Institute expects that, from the perspective of the development trend of the entire bio-economy industry, the growth rate will remain high in the next five years, and the compound growth rate will remain at around 13% in the period of 2022-2027. It is expected that for the whole year of 2022, the market size of the bio-economy industry will exceed 18 trillion yuan, and by 2027 the market size of the bio-economy industry is expected to exceed 30 trillion yuan.
For more research and analysis of this industry, please refer to China Biomedical Industry Market Outlook and Investment Strategy Planning Analysis Report by Prospect Industry Research Institute.